CYTOKINETICS INC — Director's Dealing 2022

Mar 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-03-02

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-02	Common Stock	F	5004	$37.63	Disposed	148000	Direct
2022-03-02	Common Stock	A	30000	$0.0	Acquired	178000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-02	Incentive Stock Option (right to buy)	$37.63	A	3379	Acquired	2032-03-01	Common Stock (3379)	Direct
2022-03-02	Non-Qualified Stock Option (right to buy)	$37.63	A	66621	Acquired	2032-03-01	Common Stock (66621)	Direct

Footnotes

F1: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person.

F2: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.

F3: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.